Precursor proteins that transit through the secretory pathway often require processing at specific sites in order to release their bioactive entities. The most prevalent limited proteolysis occurs at single or paired basic residues, and is achieved by one or more of the seven subtilisin-like proprotein convertases (PCs); Furin, PC1, PC2, PACE4 (paired basic amino acid converting enzyme 4), PC4, PC5 and PC7. Other types of cleavages occur at hydophobic residues, some of which are performed by subtilisin/kexin-like isozyme-1 (SKI-1), which is also known as site-1 protease. Together, the PCs and SKI-1 regulate the activity of a large variety of cellular proteins, including growth factors, neuropeptides, receptors, enzymes and even toxins and glycoproteins from infectious retroviruses. These processing events are exquisitely regulated by multiple zymogen-activation steps, as well as by specific subcellular localization signals. The above mentioned convertases are implicated in a number of pathologies such as cancer, neurodegenerative diseases, endocrine disorders and inflammation. Recently, it was recognized that the metalloendopeptidase N-arginine dibasic convertase (NRDc; nardilysin), which cleaves at the N-terminus side of basic residues in dibasic pairs, is
Introduction
While the number of functional genes within the human and rodent genomes has not yet been confirmed, it seems to be less than 100 000. However, the limited repertoire of gene products is greatly diversified by post-translational modifications, such as those that modify a single amino acid, e.g. phosphorylation, amidation, sulphation, glycosylation, acetylation, carboxymethylation, oxidation or pyroglutaminyl formation. Others involve the generation of one or more cleavage products through regulated limited proteolysis of substrates in specific subcellular compartments. In the secretory pathway, such processing often occurs at specific single or paired basic residues. This chapter concentrates on the processing of polypeptides at basic sites by (i) a family of mammalian serine proteases and (ii) the metalloendopeptidase N-arginine dibasic convertase (NRDc; nardilysin), which is present in the cytosol and at the extracellular surface. In addition, we will deal with the properties of a novel subtilisin-like enzyme that does not cleave after basic residues, called subtilisin/kexin-like isozyme 1 (SKI-1) or site 1 protease (S1P), and define its critical importance in cellular homoeostasis and in viral infections.
Proprotein convertases (PCs) and SKI-1, and their pathological implications
Processing and activation of secretory precursors Proproteins are the fundamental units from which bioactive proteins and peptides, in particular neuropeptides, are derived by limited proteolysis. Secretory precursors are usually cleaved at the general motif (Lys/Arg)-(Xaa) n -(Lys/Arg)↓, where n ϭ0, 2, 4 or 6 and Xaa is usually not Cys (↓ indicates the cleavage site). Seven mammalian PCs that cleave at the above motif have been identified since 1990 ( Figure 1 ): furin, PC1 (also called PC3), PC2, PC4, PACE4 (paired basic amino acid converting enzyme 4), PC5 (also called PC6), and PC7 [also called PC8, LPC (lymphoma PC) or SPC7 (subtilisin-like PC)] [1] [2] [3] [4] . These serine proteases belong to the yeast kexin subfamily of subtilases. Recently, a new member (SKI-1 or S1P), more closely related to pyrolysin than to kexin, was identified ( Figure 1 ). It exhibits a specificity for cleavage at the motif (Arg/Lys)-Xaa-(hydrophobic)-(Leu/Thr/Lys/Phe)↓ (↓ indicates the cleavage site) [5] . These convertases are responsible for the tissue-specific processing of multiple precursors, which often involves a cascade of cleavage events that generates diverse bioactive molecules in an exquisitely regulated manner [1] [2] [3] [4] . The C-terminus of PACE4-E contains a hydrophobic sequence that could serve as a signal for glycosylphosphatidylinositol anchoring. y, yeast; m, mouse, r, rat; h, human; GF, growth factor. The RGD motif is present in all PCs, except for PC7, in which it is replaced by an RGS motif. Processing regulation within the constitutive and regulated secretory pathways Analysis of the tissue-specific processing of substrates by PCs and SKI-1 revealed a hierarchy in the order with which these convertases cleave their cognate proproteins. Two key factors regulate this ordered process: (i) an autocatalytic zymogen activation that involves one or two cleavages resulting in the removal of the convertase pro-segment ( Figure 1 ) [4] and (ii) the subcellular localization of each enzyme ( Figure 2 ).
Autocatalytic activation of the PCs
Analysis of the biosynthesis of furin, PC1, PC2, PACE4, PC5, PC7, and SKI-1 [1] [2] [3] [4] [5] revealed that their N-terminal pro-segment acts as an intramolecular chaperone and, with the exception of PC2 and SKI-1, as a nanomolar inhibitor of its cognate enzyme. Indeed, overexpression of the pro-segments of furin, PC7 and PC5 as independent domains confirmed their inhibitory potency and revealed that the C-terminus of the pro-segment contains the critical inhibitory elements. NMR analysis of this inhibitory region in PC7 revealed that it contains an ␣-helix that is stabilized by salt bridges and H-bonds. Expression of these pro-segments in trans with enzymes in which the pro-segments have been deleted (⌬pro) did not generate highly active proteins in mammalian cells. In contrast, in yeast such an in trans complementation of ⌬pro-kexin with the prosegment led to an active protease [6] . Swapping of the pro-domains of PCs demonstrated that the pro-segment of PC1 can replace that of PACE4, and the furin pro-segment can replace that of PC1 and, to a lesser extent, PC2. The latter convertase requires a specific binding protein, 7B2 [7] , for its efficient zymogen activation.
Subcellular localization of PCs
SKI-1 is sorted to the cis/medial Golgi (Figure 2 ), which suggests that it is poised to process its cognate precursors before any other PC (Table 1) . Indeed, it is in endoplasmic reticulum (ER)/early Golgi that the processing of the four known SKI-1 substrates occurs. These include the sterol regulatory element binding proteins (SREBPs), activating transcription factor 6 (ATF6), brainderived neurotrophic factor (BDNF) and prosomatostatin (see Chapter 12 and [2] ). The next convertase in line is the PC5 isoform PC5-B, that has recently been shown to localize to an earlier, brefeldin A-collapsible, saccule of the Golgi apparatus ( Figure 2 ). Aside from being found in the trans Golgi network (TGN), furin and PC7 cycle from the cell surface to the TGN, a traffic controlled by their respective cytosolic tails (reviewed in [8] ). Precursors processed in the constitutive pathway include most growth factors, ERlocalized transcription factors, e.g. SREBPs and ATF6, adhesion molecules, surface glycoproteins and receptors such as Notch [2] . Most polypeptide prohormone processing occurs within the regulated secretory pathway and generates bioactive hormones that are secreted from mature secretory granules (SGs) in response to specific stimuli. PC1, PC2 and PC5-A (Figure 2 ), which concentrate in mature SGs, are the only PCs to enter this pathway, owing to the presence of specific domains, including two ␣-helices in the C-terminal segment of PC1 and possibly one within the last 38 amino acids of PC5-A. The cellular PC1 and PC2 activities are tightly regulated. PC1 is inhibited not only by its pro-segment, but also by the 135 amino acids of its C-termini, which contain the above-mentioned SG-targeting signals, and the novel inhibitor proSAAS [9] . The PC1-inhibitory domain within this granin-like protein has been localized [9] , peptides mimicking its effect synthesized, and the critical residues identified [10] . For PC2, the binding protein/inhibitor 7B2 is necessary for both productive folding of the enzyme, as well as to temporarily inhibit its activity via its 31-amino-acid C-terminal segment (reviewed in [7] ). No specific binding protein has yet been identified for PC5-A.
Consequences of convertase inhibition or knockout
In order to delineate the specific function of a convertase in a given cell or tissue, one needs to have methods to inhibit its expression and/or activity in a specific fashion. ␣-1Antitrypsin Portland (␣1-PDX) is an inhibitor of the constitutive secretory pathway convertases, including furin, PACE4, PC5 and PC7 ( Figure 2 ). We demonstrated recently that when the colon adenocarcinoma cell line HT-29 overexpresses this serpin, the cells are more prone to apoptosis and are less likely to form tumours in nude mice [11] . Preliminary data also showed that the potential of these cells to metastasize to the liver is lower than for the parental cells [12] . Pituitary AtT20 cells that overexpress ␣1-PDX also show an increased apoptotic phenotype and decreased growth and foci formation on soft agar. To provide insight into the genes that favour tumour formation and metastasis, we began to compare the gene expression profile of AtT20 and HT-29 cells, in presence or absence of ␣1-PDX, using both microarray (for mRNA) and proteomic two-dimensional gel (for protein) technologies. Microarray analysis of mouse AtT20 cell mRNA revealed the substantial indirect up-or down-regulation of approx. 18 gene products by ␣1-PDX. The most prominent down-regulated mRNA was that of the growth factor-inducible DNA-binding inhibitor Id3 (19-fold downregulation), which plays a vital role in the proliferation of many cell types. This suggests that blocking the processing of certain growth factors, such as platelet-derived growth factor, or their receptors may indirectly signal to down-regulate Id3. Among the major up-regulated mRNAs were thymosin ␤4 (42-fold upregulation) and somatostatin receptor-1 (45-fold upregulation). Thymosin ␤4 binds to monomeric actin and prevents spontaneous polymerization of actin monomers into filaments. It remains to be seen whether metastasis is more or less pronounced in these cells. There is still much to be learned about the consequences of inhibiting each individual PC, in terms of both mRNA and protein expression. One of the major problems encountered with the PC inhibitors is that none of them is absolutely specific for the cognate convertase, except for proSAAS (for inhibiting PC1) [9, 10] and 7B2 (for inhibiting PC2) [7] . Knockout of the PC2, PC4 [1] [2] [3] [4] [5] , PACE4 or PC7 (E. Robertson and D. Constam, personal communication) genes resulted in viable animals with relatively mild phenotypes. In contrast, furin knockout mice are embryonic lethal. We have not yet been able to obtain PC1 Ϫ/Ϫ mice, even though PC1 ϩ/Ϫ mice are readily born (M. Mbikay, N.G. Seidah and M. Chretien unpublished work). Thus far, no PC5 null mice have been produced. Recently, the SKI-1 Ϫ/Ϫ genotype was found to be lethal to mouse embryos and a conditional SKI-1 knockout in liver clearly emphasized the role of this convertase in cholesterol and lipid metabolism [13] . In conclusion, the availability of single PC-null mice and/or transgenic overexpressors (and their crosses) enriches our understanding of the biological functions of PCs and provides models of pathologies that should lead ultimately to the identification of their physiological substrates.
Role of PCs in neurodegenerative pathologies: Alzheimer's disease
The proteins amyloid-␤ protein precursor (␤APP), presenilin 1 and presenilin 2 have been implicated in the early-onset autosomal dominant Alzheimer's disease (reviewed in [14] ; see also Chapter 4). Mutations in these three genes account for 50% of all inherited Alzheimer's disease cases. A fourth gene that is implicated in familial Alzheimer's disease is the apolipoprotein E gene, as patients carrying its ⑀4 allele show an increased density of amyloid-␤ protein (A␤) deposits [14] . All mutant genes that cause Alzheimer's disease increase the concentration of A␤ 42 , which appears to be especially prone to forming plaques, suggesting that this process is a fundamental alteration leading to pathogenesis. Intense efforts have been directed towards the identification of the proteases involved in the processing of APP, i.e. the ␣-, ␤-and ␥-secretases. The PCs seem to play an indirect role in Alzheimer's disease through the zymogen processing of both ␣-and ␤-secretases.
␣-Secretase
Cleavage by ␣-secretase within the His-His-Gln-Lys 668 ↓Leu-Val sequence of ␤APP is the major physiological route of maturation. This cleavage precludes the formation of insoluble A␤ and is therefore non-amyloidogenic. Studies aimed at identifying ␣-secretase(s) candidates suggest the involvement of enzymes belonging to the ADAM (a disintegrin and metalloproteinase) and PC families, including ADAM10 (kuzbanian) and ADAM17 (tumour necrosis factor-␣-converting enzyme) (see Chapter 11) . ADAM proteinases are first synthesized as zymogens that require activation in the TGN by as yet unidentified PC-like enzymes. We demonstrated that inhibition of PCs by ␣1-PDX blocks the ␣-secretase-mediated cleavage of ␤APP, while overexpression of PC7 enhances it [15] . Furthermore, PC7 and ADAM10, but not ADAM17, are likely to contribute to the constitutive secretion of soluble APP␣ by human LoVo cells [16] . It is thus possible that PC7 is involved in the processing of proADAM10 either directly or indirectly. Both enzymes cycle between the TGN and the cell surface, and are thus present in compartments thought to display ␣-secretase activity. Thus, ␣-secretase activity depends on the availability of convertase(s), e.g. PC7 and possibly furin.
␤-Secretase
The amyloidogenic pathway that generates A␤ starts with ␤-secretase cleaving APP at the Glu-Val-Lys-Met 652 ↓Asp-Ala sequence, or of its Swedish mutant form at Glu-Val-Asn-Leu 652 ↓Asp-Ala. This results in the generation of a membrane-bound 99-amino-acid peptide (approx. 10 kDa), known as C99. Very recently, five different groups simultaneously reported the isolation and initial characterization of the human aspartyl proteinase ␤-secretase (reviewed in [17] ). The major ␤-secretase candidate is ␤-site APP-cleaving enzyme (BACE), a type-I membrane-bound protein with a prodomain that is rapidly cleaved intracellularly for maximal activation and cellular sorting of the proteinase. Since the processing site of the BACE pro-segment is similar to PC-cleavage sites (Figure 3) , we studied the involvement of PCs in the biosynthesis of BACE as well as the molecular properties and cellular trafficking of this enzyme [18] . Our biosynthesis and microsequencing data demonstrated that furin and PC5 are the major PCs responsible for the conversion of proBACE (starting at the Thr 22 -His-Leu-Gly-Ile-Arg sequence) into BACE within the TGN by cleavage at the Arg-Leu-Pro-Arg 45 ↓Glu 46 -Thr-Asp-Glu-Glu site [18] . Characteristics that are particular to BACE include palmitoylation at the three cysteine residues within its cytosolic tail and sulphation at one or more of its carbohydrate moieties. Palmitoylation of BACE may be critical for its entry into lipid rafts wherein ␥-secretase is also thought to be active
Role of SKI-1/S1P in viral infections
Thus far, SKI-1/S1P has been implicated in the processing of SREBPs, ATF6 (see also Chapter 12) and the neuropeptide precursors of BDNF and somatostastin [2] . Thus, aside from its fundamental role in cholesterol and fatty acid homoeostasis (see Chapter 12) , this enzyme may also have other unsuspected functions such as cleavage of particular viral glycoproteins. Many enveloped viruses, such as influenza viruses, paramyxoviruses, HIV and filoviruses, have fusion proteins that undergo post-translational proteolytic processing by host proteases. In most cases, cleavage is an important biological control mechanism, since it triggers fusion activity and is thus essential for virus entry into the host cell. Data on various viruses showed that endoproteolytic cleavage of envelope glycoproteins by one or more PCs is required for the acquisition of fusogenic potential and therefore for the infectious capacity of viral particles. As in the case of viral glycoprotein precursors, activation of some bacterial toxins also requires maturation by a convertase of the PC-family. For the HIV envelope glycoproptein, this maturation occurs within the constitutive secretory pathway where PCs such as furin, PC5-B and PC7 are localized (reviewed in [1] [2] [3] ). Lassa virus (LAV) is the causative agent of a haemorrhagic fever that is endemic in West Africa. LAV belongs to the family of Arenaviridae, which also includes lymphocytic choriomeningitis virus (LCMV), Mopeia virus and the New World arenaviruses, such as the Junin and Machupo viruses. Virions are composed of a nucleocapsid surrounded by a lipid-containing envelope and viral glycoprotein spikes. The LAV glycoprotein is synthesized as a 76-kDa precursor glycoprotein (GP-C) that is post-translationally cleaved into the Nterminal subunit GP-1 (44 kDa) and the C-terminal fragment GP-2 (36 kDa) containing the membrane anchor ( Figure 4) . It has been shown that LCMV and Junin virus glycoprotein cleavage occurs in the Golgi apparatus or a post-Golgi compartment. GP-1 of LCMV and of LAV interacts with a host cell-surface receptor that has been identified recently as ␣-dystroglycan, while the ectodomain of GP-2 contains a fusion peptide. After cleavage of the LCMV and Junin virus glycoprotein, the fusion peptide appears to be exposed by a conformational change in a pH-dependent manner to mediate fusion. Recently, the cleavage site of LAV GP-C (Arg-Arg-Leu-Leu 259 ↓Gly-Thr-Phe) was identified [19] . Systematic mutagenesis revealed that the recognition motif is Arg-Xaa-(Leu/Ile/Val)-Leu 259 ↓ and that SKI-1 is indeed the cognate convertase [20] . This led to the development of a rapid, sensitive and specific enzymic assay for SKI-1 using a quenched fluorogenic substrate that mimics the GP-C cleavage site [21] that is far superior to those reported previously [5] . The sequence conservation of cleavage sites (Figure 4) indicates that SKI-1 may cleave most Areanviridae and Bunyaviridae glycoproteins.
GP-C is the first viral glycoprotein known to be processed by SKI-1, and not by PCs. Treatment with the guanosine analogue ribavarin is the only available therapy for Lassa fever in humans, but is effective only if started very early. Specific inhibitors of SKI-1/S1P may lead to new therapeutic approaches for Lassa fever and for the devastating Arenavirus-mediated haemorraghic fever.
NRDc: a cytosolic and cell surface dibasic convertase
The acronym NRDc reflects the preference of the enzyme for cleaving at the N-terminus of arginine residues in basic doublets. It can, however, cleave upstream of lysine residues in dibasic motifs [22] . The endopeptidase cleaves dynorphin A (at Arg↓Arg); ␣-neoendorphin (at Lys↓Arg) and somatostatin-28 (at ↓Arg-Lys) in vitro [23] . It is unlikely that these peptides constitute bona fide in vivo substrates since the enzyme is present mainly in the cytosol and seems unable to transit through the secretory pathway [24] . The enzyme is also exported at the cell surface and/or in the extracellular milieu [24, 25] . The cleavage specificity of NRDc suggests that it may be involved in limited intracellular or extracellular proteolysis. Thus far, none of its cytosolic and/or extracellular substrate(s) have been identified.
Two cDNAs encoding alternatively spliced forms of NRDc were isolated from cDNA libraries from rat and human testes. While the minor isoform contains an extra 68 residues close to the active site, no functional difference was observed between the two isforms [24] . Therefore NRDc will refer to the major NRDc isoform 1. The predicted rat protein (1161 amino acids; 133 kDa) shows an inverted consensus binding site for the catalytic Zn 2ϩ , His-Xaa-XaaGlu-His, compared with the His-Glu-Xaa-Xaa-His sequence that is found in most metallopeptidases. This unambiguously classified the enzyme in the inverzincin/M16 family of metalloendopeptidases [26, 27] . Another feature of the sequence is the presence of a 71-amino-acid acidic stretch (79% GluϩAsp), which is located approx. 30 residues upstream from the His-Xaa-Xaa-Glu-His motif ( Figure 5 ) [23] .
The closest mammalian member to NRDc is insulin-degrading enzyme (IDE; insulysin) with 36% overall identity and 47% identity in the conserved catalytic region. Several other members of the inverzincin/M16 family are involved in peptide/protein degradation as well as in peptide/protein processing, such as Axl1, which N-terminally processes the yeast cytosolic mating afactor. Another characteristic of some members of this family, including NRDc, is their bifunctionality. For example, in addition to its protease activi- 
NRDc acidic domain
NRDc was the first member of the family shown to have an insertion (90 amino acids) in this region, which is composed of its acidic stretch extended by 12 N-terminal and seven C-terminal residues (acidic domain; DAC). We recently identified, in data banks, six members presenting acidic or non-acidic insertions at exactly the same position ( Figure 5 ). While the proteins from Arabidopsis thaliana and Fugu rubripes (the Japanese puffer fish) also show acidic insertions, those from zebrafish and Drosophila melanogaster are serineand glutamine-rich. The latter comprise phosphorylation sites and may thus be more negatively charged than expected from the number of glutamine residues. Interestingly, in addition to its SET (serine-, glutamine-and threonine-rich) domain, D. melanogaster CG2025 also shows an acidic stretch at its In NRDc, the 90-amino-acid acidic domain is not required for catalytic activity, suggesting that it constitutes an appendix to the global enzyme structure that is not required for its folding [28] .
Cellular and subcellular distribution
NRDc transcripts are particularly abundant in the testes, skeletal muscle and heart. During mouse development, NRDc transcripts appear first in the central nervous system and cephalic and spinal ganglia (embryonic day 10.5), and later on in many other tissues [29] . In the testes, NRDc is only detected in germ cells and is associated with the axoneme of the flagellum [25] . Although it is mainly a cytosolic protein, NRDc is also secreted by germ cells and by various cell lines, and can be retained at the cell surface, though it is devoid of a transmembrane domain. This intracellular/extracellular localization of NRDc, also observed for IDE and the metalloendopeptidases 24.15 and 24.16, raises the question of the mechanism of its export, which is still not known.
NRDc modulates the heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) cellular response and is potently inhibited by HB-EGF
In addition to its peptidase activity, NRDc binds with a high affinity to HB-EGF at the cell surface (K d ϭ0.5-5 nM) and regulates its activity [30] . HB-EGF is a potent stimulator of cell proliferation and migration, and is implicated in various physiological processes such as wound healing, blastocyst implantation, smooth muscle cell hyperplasia, atherosclerosis and tumour growth. NRDc levels, modulated by overexpression and antisense Morpholino oligomers, appear to correlate with the observed enhancement of the HB-EGF-induced response [30] . Although the molecular mechanism of this potentiation remains to be elucidated, NRDc may promote the interaction of soluble HB-EGF with its receptor. In addition, its enzyme activity is not required since an active site mutant enhances HB-EGF-induced migration to the same degree as the wildtype enzyme [30] . It is noteworthy that NRDc does not bind to other growth factors of the EGF family and is thus specific for HB-EGF. While NRDc modulates the cellular response induced by HB-EGF, the latter in turn regulates NRDc enzyme activity, since it is a potent inhibitor with an IC 50 of approx. 100 nM. The NRDc-HB-EGF interaction relies on the 21-amino-acid basic heparin-binding domain of HB-EGF and the acidic domain of NRDc [28] . An NRDc mutant that lacks this domain is approx. 6-fold less sensitive to HB-EGF and when expressed at the cell surface, does not bind HB-EGF.
Finally, through its acidic domain, NRDc's enzymic activity as well as its HB-EGF binding may be regulated by extracellular Ca 2ϩ .
Conclusions
Within the last decade the longstanding goal of identifying the convertases involved in the limited proteolysis of secretory proteins has been largely achieved. The identification of the seven kexin-like PCs and the pyrolysin-like SKI-1/S1P has paved the way to major advances in our understanding of the proteolytic machinery that regulates multiple homoeostatic and pathological events. While these secretory processes are now better understood, the study of similar cleavages occurring within the cytosol and/or at the cell surface is in an explosive phase. NRDc cleavage specificity and the presence of the enzyme in both cytosol and cell surface suggest that it may be an equivalent to the PCs in these compartments.
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